Altered Fibrin Clot Properties in Patients With Cerebral Venous Sinus Thrombosis: Association With the Risk of Recurrence
- PMID: 26173730
- DOI: 10.1161/STROKEAHA.115.009528
Altered Fibrin Clot Properties in Patients With Cerebral Venous Sinus Thrombosis: Association With the Risk of Recurrence
Abstract
Background and purpose: Venous thromboembolism and ischemic stroke are associated with unfavorable fibrin clot structure and function. We hypothesized that denser fibrin networks displaying impaired lysability characterize patients with cerebral venous sinus thrombosis (CVST).
Methods: We assessed plasma fibrin clot properties in 50 patients (aged 38.9±9.8 years, 36 women) after the first CVST unrelated to trauma or malignancy after anticoagulation withdrawal and 50 well-matched controls. Recurrences were recorded during follow-up (18-46; median, 36 months).
Results: Clot permeability was lower in patients with CVST than in controls (Ks, 6.43±0.97 versus 7.3±1.2 10(-9) cm(2); P<0.001) and was associated with prolonged clot lysis time (103.0±16.8 versus 92.4±16.2 minutes; P<0.001), lower maximum rate of D-dimer release from clots (0.068 [0.064-0.071] versus 0.072 [0.067-0.078] mg/L per minute; P<0.001) and higher maximum D-dimer levels in the lysis assay (4.39±0.56 versus 4.19±0.46 mg/L, respectively; P=0.03). Patients with CVST had a slightly shorter lag phase (P=0.02) and higher maximum absorbance of fibrin gels on turbidimetry (P<0.001) compared with controls. Deficiencies in natural anticoagulants or antiphospholipid syndrome, and factor V Leiden occurred more often in the patients (P<0.05). CVST recurred in 6 patients (12%) and was associated with 21% higher baseline fibrinogen (P=0.007), 20% lower Ks (P=0.04) and 17% greater D-Dmax (P=0.01). Multiple logistic regression showed that only elevated D-Dmax (>4.83 mg/L) predicted CVST recurrence (odds ratio, 5.1; 95% confidence interval, 1.63-16.19) after adjustment for fibrinogen.
Conclusions: CVST is associated with the formation of more compact plasma fibrin clots and resistance to fibrinolysis, which may predispose to the recurrence.
Keywords: fibrin; fibrinolysis; recurrence; stroke.
© 2015 American Heart Association, Inc.
Similar articles
-
Elevated lipoprotein(a) as a new risk factor of cerebral venous sinus thrombosis: association with fibrin clot properties.J Thromb Thrombolysis. 2019 Jan;47(1):8-15. doi: 10.1007/s11239-018-1769-0. J Thromb Thrombolysis. 2019. PMID: 30511257 Free PMC article.
-
Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.Eur J Clin Invest. 2014 Jun;44(6):557-66. doi: 10.1111/eci.12269. Eur J Clin Invest. 2014. PMID: 24738991
-
Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):365-373. doi: 10.1161/ATVBAHA.116.308253. Epub 2016 Dec 29. Arterioscler Thromb Vasc Biol. 2017. PMID: 28062504
-
Altered fibrin clot properties and fibrinolysis in patients with atrial fibrillation: practical implications.Europace. 2020 Feb 1;22(2):185-194. doi: 10.1093/europace/euz271. Europace. 2020. PMID: 31625555 Review.
-
Fibrin clot properties and their modulation in thrombotic disorders.Thromb Haemost. 2014 Jul 3;112(1):32-42. doi: 10.1160/TH14-01-0032. Epub 2014 Mar 27. Thromb Haemost. 2014. PMID: 24671700 Review.
Cited by
-
C-reactive protein and D-dimer in cerebral vein thrombosis: Relation to clinical and imaging characteristics as well as outcomes in a French cohort study.Res Pract Thromb Haemost. 2023 Mar 28;7(3):100130. doi: 10.1016/j.rpth.2023.100130. eCollection 2023 Mar. Res Pract Thromb Haemost. 2023. PMID: 37138790 Free PMC article.
-
Elevated factor XI is associated with increased risk of recurrent cerebral venous sinus thrombosis: a cohort study.J Thromb Thrombolysis. 2024 Mar;57(3):402-407. doi: 10.1007/s11239-023-02935-2. Epub 2023 Dec 25. J Thromb Thrombolysis. 2024. PMID: 38145433 Free PMC article.
-
Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence.Biomed Res Int. 2017;2017:8196256. doi: 10.1155/2017/8196256. Epub 2017 Jun 27. Biomed Res Int. 2017. PMID: 28740853 Free PMC article. Review.
-
Insights into the composition of stroke thrombi: heterogeneity and distinct clot areas impact treatment.Haematologica. 2020 Jan 31;105(2):257-259. doi: 10.3324/haematol.2019.238816. Print 2020. Haematologica. 2020. PMID: 32005654 Free PMC article. No abstract available.
-
Interpretation and Validation of Maximum Absorbance Data Obtained from Turbidimetry Analysis of Plasma Clots.Thromb Haemost. 2020 Jan;120(1):44-54. doi: 10.1055/s-0039-1698460. Epub 2019 Nov 21. Thromb Haemost. 2020. PMID: 31752041 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources